Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biogen Idec (NQ: BIIB ) 226.40 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 245 Open 226.40 Bid (Size) 225.39 (1) Ask (Size) 228.69 (1) Prev. Close 226.40 Today's Range 226.40 - 226.40 52wk Range 189.44 - 280.41 Shares Outstanding 144,000,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB) July 19, 2024 From The Law Offices of Frank R. Cruz Via Business Wire BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm July 19, 2024 From The Schall Law Firm Via Business Wire Performance YTD -15.43% -15.43% 1 Month +1.07% +1.07% 3 Month +16.63% +16.63% 6 Month -8.82% -8.82% 1 Year -18.27% -18.27% More News Read More SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen July 18, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Key Takeaways From Biogen Analyst Ratings July 12, 2024 Via Benzinga Will BIOGEN INC breakout? July 11, 2024 Via Chartmill Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense July 16, 2024 Via Investor's Business Daily BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm July 16, 2024 From Schall Law Via GlobeNewswire Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings' July 15, 2024 Via Benzinga Topics Bankruptcy Exposures Financial Legal BIOGEN INC. (NASDAQ: BIIB) SHAREHOLDER ALERT: Only 7 Days Remain For Investors To Move For Lead Plaintiff in Biogen Inc. July 15, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split July 15, 2024 Via The Motley Fool Did Eli Lilly Just Get a Leg Up on Novo Nordisk? July 13, 2024 Via The Motley Fool DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen July 12, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors of Class Action Filing and Encourages Investors to Contact the Firm July 11, 2024 From Kirby McInerney LLP Via GlobeNewswire BIIB Investors Have Opportunity to Join Biogen Inc. Securities Fraud Investigation with the Schall Law Firm July 11, 2024 From The Schall Law Firm Via Business Wire BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm July 09, 2024 From Schall Law Via GlobeNewswire BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline July 08, 2024 From Bernstein Liebhard LLP Via GlobeNewswire 3 Highly Rated Biotech Stocks for Your July Buy List July 05, 2024 Via InvestorPlace SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen July 04, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst July 03, 2024 Via Benzinga Exposures Product Safety BIIB STOCKHOLDERS: Lead Plaintiff Deadline Approaching in Biogen Inc. Class Action; Contact Robbins LLP July 02, 2024 From Robbins LLP Via GlobeNewswire Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai July 02, 2024 Via Investor's Business Daily BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm July 02, 2024 From Schall Law Via GlobeNewswire Biogen Completes Acquisition of Human Immunology Biosciences July 02, 2024 From Biogen Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, Fastly, and NIKE and Encourages Investors to Contact the Firm July 01, 2024 From Bragar Eagel & Squire Via GlobeNewswire BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline July 01, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.